Detailed information of AR

Dataset summary

TF Name: AR Species: Mus musculus
Cell-type/Tissue: kidney Condition/Source: castrated+testosterone
JASPAR ID: MA0007.3 Collections: Permissive Robust
References: GEO GSE47192 GSM1146474 GSM1146475 GTRD EXP032178

External links

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA0007.3 78 9208 80.5 -34.6199653369804

307 datasets found for the same TF (AR) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
AR mdamb453 shfoxa1 Permissive Robust Homo sapiens ERP003272 MA0007.3
AR LNCaP (prostate carcinoma) kdp53 Permissive Robust Homo sapiens GSE31294 MA0007.3
AR LNCaP (prostate carcinoma) abl Permissive Robust Homo sapiens GSE39459 MA0007.3
AR mdamb453 dht Permissive Robust Homo sapiens GSE45201 MA0007.3
AR LNCaP (prostate carcinoma) shctr Permissive Robust Homo sapiens GSE47120 MA0007.3
AR ar dht1nm Permissive Robust Homo sapiens GSE48308 MA0007.3
AR foxa1 hoxb13 Permissive Robust Homo sapiens GSE56288 MA0007.3
AR prostate dht Permissive Robust Homo sapiens GSE61838 MA0007.3
AR ducap androgen Permissive Robust Homo sapiens GSE70679 MA0007.3
AR LNCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE28126 ... MA0007.3
AR LNCaP (prostate carcinoma) AR stimulated Permissive Robust Homo sapiens GSE28126 ... MA0007.3
AR VCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE28126 ... MA0007.3
AR VCaP (prostate carcinoma) AR stimulated Permissive Robust Homo sapiens GSE28126 ... MA0007.3
AR VCaP (prostate carcinoma) NT Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR VCaP (prostate carcinoma) siERG Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR LNCaP (prostate carcinoma) 10nm R Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR LNCaP (prostate carcinoma) 1nm R Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR LNCaP (prostate carcinoma) ethanol Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR LNCaP (prostate carcinoma) R1881 Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR VCaP (prostate carcinoma) ethanol Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR VCaP (prostate carcinoma) R1881 Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR LNCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR LNCaP (prostate carcinoma) 1000 nM Bica Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR LNCaP (prostate carcinoma) 100 nM DHT Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR LNCaP (prostate carcinoma) 100 nM DHT+Dex Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR LNCaP (prostate carcinoma) 1000 nM CPA Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR LNCaP (prostate carcinoma) 1000 nM RU486 Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR VCaP (prostate carcinoma) 100 nM DHT Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR VCaP (prostate carcinoma) DHT for 4h Permissive Robust Homo sapiens GSE32345 ... MA0007.3
AR VCS2 (prostate carcinoma) DHT for 4h Permissive Robust Homo sapiens GSE32345 ... MA0007.3
AR kidney castrated+vehicle Permissive Robust Mus musculus GSE47192 ... MA0007.3
AR caput epididymis castrated+vehicle Permissive Robust Mus musculus GSE47192 ... MA0007.3
AR prostate castrated+vehicle Permissive Robust Mus musculus GSE47192 ... MA0007.3
AR prostate castrated+testosterone Permissive Robust Mus musculus GSE47192 ... MA0007.3
AR caput epididymis intact Permissive Robust Mus musculus GSE47192 ... MA0007.3
AR caput epididymis specificity affecting androgen receptor knock-in Permissive Robust Mus musculus GSE51106 ... MA0007.3
AR caput epididymis specificity affecting androgen receptor knock-in Permissive Robust Mus musculus GSE51106 ... MA0007.3
AR ventral prostate specificity affecting androgen receptor knock-in Permissive Robust Mus musculus GSE51106 ... MA0007.3
AR LNCaP (prostate carcinoma) BICALUTAMIDE Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) BICALUTAMIDE Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) BICALUTAMIDE Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) BICALUTAMIDE Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR LNCaP (prostate carcinoma) Vehicle Permissive Robust Homo sapiens GSE49832 ... MA0007.3
AR HEK293 (embryonic kidney) Ethanol Permissive Robust Homo sapiens GSE54109 ... MA0007.3
AR HEK293 (embryonic kidney) 10 nM R1881 Permissive Robust Homo sapiens GSE54109 ... MA0007.3
AR HEK293 (embryonic kidney) 10 nM R1881 Permissive Robust Homo sapiens GSE54109 ... MA0007.3
AR LNCaP (prostate carcinoma) Bicalutamide Permissive Robust Homo sapiens GSE51063 ... MA0007.3
AR LNCaP (prostate carcinoma) Enzalutamide Permissive Robust Homo sapiens GSE51063 ... MA0007.3
AR LNCaP C4-2 (prostate carcinoma) ethanol Permissive Robust Homo sapiens GSE55031 ... MA0007.3
AR LNCaP C4-2 (prostate carcinoma) 10 nmol/l of mibolerone Permissive Robust Homo sapiens GSE55031 ... MA0007.3
AR LNCaP (prostate carcinoma) ethanol Permissive Robust Homo sapiens GSE55031 ... MA0007.3
AR LNCaP (prostate carcinoma) 10 nmol/l of mibolerone Permissive Robust Homo sapiens GSE55031 ... MA0007.3
AR ovarian granulosa cells Insertion Permissive Robust Homo sapiens GSE58628 ... MA0007.3
AR ovarian granulosa cells Deletion Permissive Robust Homo sapiens GSE58628 ... MA0007.3
AR CWR22 (prostate carcinoma) DHT Permissive Robust Homo sapiens GSE62442 ... MA0007.3
AR CWR22 (prostate carcinoma) DHT+Bicalutamide Permissive Robust Homo sapiens GSE62442 ... MA0007.3
AR CWR22 (prostate carcinoma) DHT+MDV3100 Permissive Robust Homo sapiens GSE62442 ... MA0007.3
AR prostate tumor castrate Permissive Robust Mus musculus GSE62645 ... MA0007.3
AR prostate tumor bicalutamide Permissive Robust Mus musculus GSE62645 ... MA0007.3
AR prostate tumor enzalutamide Permissive Robust Mus musculus GSE62645 ... MA0007.3
AR LNCaP C4-2 (prostate carcinoma) ethanol Permissive Robust Homo sapiens GSE65066 ... MA0007.3
AR LNCaP C4-2 (prostate carcinoma) 10 nmol/l of mibolerone Permissive Robust Homo sapiens GSE65066 ... MA0007.3
AR LNCaP (prostate carcinoma) ethanol Permissive Robust Homo sapiens GSE65066 ... MA0007.3
AR LNCaP (prostate carcinoma) 10 nmol/l of mibolerone Permissive Robust Homo sapiens GSE65066 ... MA0007.3
AR LNCaP (prostate carcinoma) Bicalutamide 1 μM Permissive Robust Homo sapiens GSE66037 ... MA0007.3
AR BicR (prostate cancer) DHT 10 nM Permissive Robust Homo sapiens GSE66037 ... MA0007.3
AR BicR (prostate cancer) Bicalutamide 1 μM Permissive Robust Homo sapiens GSE66037 ... MA0007.3
AR BicR (prostate cancer) ethanol Permissive Robust Homo sapiens GSE66037 ... MA0007.3
AR VCaP (prostate carcinoma) siControl Permissive Robust Homo sapiens GSE77770 ... MA0007.3
AR VCaP (prostate carcinoma) siOCT1 Permissive Robust Homo sapiens GSE77770 ... MA0007.3
AR LNCaP (prostate carcinoma) siControl Permissive Robust Homo sapiens GSE77770 ... MA0007.3
AR LNCaP (prostate carcinoma) siOCT1 Permissive Robust Homo sapiens GSE77770 ... MA0007.3
AR LNCaP (prostate carcinoma) 72 hour CDT + 3 hour EtOH Permissive Robust Homo sapiens GSE82202 ... MA0007.3
AR LNCaP (prostate carcinoma) treated for 24 hours with 0.5μM PD-0332991 +3 hour 10nm DHT Permissive Robust Homo sapiens GSE82202 ... MA0007.3
AR LNCaP (prostate carcinoma) treated for 24 hours with 5μg/mL roscovitine + 3 hour DHT Permissive Robust Homo sapiens GSE82202 ... MA0007.3
AR LNCaP (prostate carcinoma) treated for 24 hours with 2μg/mL aphidicolin +3 hour 10nm DHT Permissive Robust Homo sapiens GSE82202 ... MA0007.3
AR LNCaP (prostate carcinoma) treated for 24 hours with 1mM hydroxyurea +3 hour 10nm DHT Permissive Robust Homo sapiens GSE82202 ... MA0007.3
AR LNCaP (prostate carcinoma) 2μg/mL aphidicolin for 15 hours, followed by washout and treatment with 50ng/mL nocodozole for 9 hours +3 hour 10nm DHT Permissive Robust Homo sapiens GSE82202 ... MA0007.3
AR R1-D567 (prostate cancer) radiation Permissive Robust Homo sapiens GSE102164 ... MA0007.3
AR LNCaP (prostate carcinoma) R1881 Permissive Robust Homo sapiens GSE73994 ... MA0007.3
AR LNCaP (prostate carcinoma) R1881+Doxycycline Permissive Robust Homo sapiens GSE73994 ... MA0007.3
AR LNCaP (prostate carcinoma) NOV induced Permissive Robust Homo sapiens GSE79357 ... MA0007.3
AR VCaP (prostate carcinoma) dihydrotestosterone (DHT) Permissive Robust Homo sapiens GSE92347 ... MA0007.3
AR VCaP (prostate carcinoma) Control Permissive Robust Homo sapiens GSE92347 ... MA0007.3
AR LNCaP (prostate carcinoma) dihydrotestosterone (DHT) Permissive Robust Homo sapiens GSE92347 ... MA0007.3
AR LNCaP (prostate carcinoma) Control Permissive Robust Homo sapiens GSE92347 ... MA0007.3
AR LNCaP (prostate carcinoma) dihydrotestosterone (DHT) Permissive Robust Homo sapiens GSE92347 ... MA0007.3
AR LNCaP (prostate carcinoma) Control Permissive Robust Homo sapiens GSE92347 ... MA0007.3
AR breast tumor Female Permissive Robust Homo sapiens GSE104399 ... MA0007.3
AR MCF-7 C4-12 (invasive breast ductal carcinoma) Female Permissive Robust Homo sapiens GSE104399 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation , ethanol, knockout control Genotype: wildtype Source: prostate cancer cells Permissive Robust Homo sapiens GSE108144 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation, ethanol, shTRIM24 Genotype: wildtype Source: prostate cancer cells Permissive Robust Homo sapiens GSE108144 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: CaP cells were infected with EZH2 knockdown lentivirus and maintained for 2-3 days before fixation, ethanol , shTRIM28 Genotype: wildtype Source: prostate cancer cells Permissive Robust Homo sapiens GSE108144 ... MA0007.3
AR HEE (human epididymis epithelial cells) Treatment: without treatment of R1881 (methyltrienolone) Permissive Robust Homo sapiens GSE109061 ... MA0007.3
AR HEE (human epididymis epithelial cells) Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr Permissive Robust Homo sapiens GSE109061 ... MA0007.3
AR HEE (human epididymis epithelial cells) Treatment: without treatment of R1881 (methyltrienolone) Permissive Robust Homo sapiens GSE109061 ... MA0007.3
AR HEE (human epididymis epithelial cells) Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr Permissive Robust Homo sapiens GSE109061 ... MA0007.3
AR A375 (malignant melanoma) Genotype: empty vector Tissue: skin Treatment: Cells were transfected with pcDNA3.1(-) empty vector control for 24 hr, post-seeding using Lipofectamine 2000 Permissive Robust Homo sapiens GSE116189 ... MA0007.3
AR A375 (malignant melanoma) Genotype: empty vector Tissue: skin Treatment: Cells were transfected with pcDNA3.1(-) vector expressing SLNCR1 for 24 hr, post-seeding using Lipofectamine 2000 Permissive Robust Homo sapiens GSE116189 ... MA0007.3
AR LNCaP-abl (Prostate carcinoma) Treatment: vehicle (DMSO) of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive Permissive Robust Homo sapiens GSE80238 ... MA0007.3
AR LNCaP-abl (Prostate carcinoma) Treatment: EPZ-6438 of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive Permissive Robust Homo sapiens GSE80238 ... MA0007.3
AR LNCaP-abl (Prostate carcinoma) Treatment: GSK126 of 5 uM for 4-5 days Passages: 61-64 Phenotype: AR-positive, EZH2 inhibitor -sensitive Permissive Robust Homo sapiens GSE80238 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: non-target siNT+R1881 Permissive Robust Homo sapiens GSE80742 ... MA0007.3
AR 22RV1 (prostate carcinoma) treatment: targeting ARV1/3/4/7 siARVs+R1881 Permissive Robust Homo sapiens GSE80742 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: targeting AR exon 7 siARFL+ ethanol Permissive Robust Homo sapiens GSE80742 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: wildtype Permissive Robust Homo sapiens GSE85558 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression Permissive Robust Homo sapiens GSE85558 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: wildtype Permissive Robust Homo sapiens GSE85558 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G Permissive Robust Homo sapiens GSE85558 ... MA0007.3
AR hNSC (neural stem cells) Treatment: DMSO 4 hours Permissive Robust Homo sapiens GSE86454 ... MA0007.3
AR hNSC (neural stem cells) Treatment: DHT 10nM 4 hours Permissive Robust Homo sapiens GSE86454 ... MA0007.3
AR hNSC (neural stem cells) Treatment: Testosterone 100nM 4 hours Permissive Robust Homo sapiens GSE86454 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: DMSO 4 hours Permissive Robust Homo sapiens GSE86456 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: DMSO 4 hours Permissive Robust Homo sapiens GSE86456 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: DHT 100nM 4 hours Permissive Robust Homo sapiens GSE86456 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: DHT 100nM 4 hours Permissive Robust Homo sapiens GSE86456 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: control Permissive Robust Homo sapiens GSE120738 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: exclude Permissive Robust Homo sapiens GSE120738 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: case Permissive Robust Homo sapiens GSE120738 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Ethanol for 4 hrs Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nM DHT for 4 hrs Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and vector Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and vector Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Ethanol for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout and Bag-1L wildtype Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Ethanol for 4 hrs Genotype: Bag-1L wildtype Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L wildtype Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: Ethanol for 4 hrs Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nM DHT for 4 hrs Genotype: Bag-1L knockout Permissive Robust Homo sapiens GSE89938 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: vehicle (charcoal stripped) for 6 hrs TF: full-length AR (AR-FL) Permissive Robust Homo sapiens GSE94013 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: 10 nM DHT for 6 hrs TF: full-length AR (AR-FL) Permissive Robust Homo sapiens GSE94013 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: 10 nM DHT+ 500 nM JQ1 for 6 hrs TF: full-length AR (AR-FL) Permissive Robust Homo sapiens GSE94013 ... MA0007.3
AR 22RV1 (prostate carcinoma) Treatment: 10 nM DHT+10 uM MDV3100 TF: full-length AR (AR-FL) Permissive Robust Homo sapiens GSE94013 ... MA0007.3
AR HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells Treatment: 24h ethanol Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 24h DHT 1 nM Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR LTAD (long term androgen deprivation) Treatment: 24h DHT 1 nM Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR VCaP and LTAD cells Treatment: 24h DHT 10 nM Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR VCaP and LTAD cells Treatment: 24h DHT 1 nM Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR LTAD (long term androgen deprivation) Treatment: 24h DHT 10 nM siControl treated Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR LTAD (long term androgen deprivation) Treatment: 24h DHT 10 nM siCOBLL1 treated Permissive Robust Homo sapiens GSE94577 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: treated with 10nM vehicle for 4 hours Permissive Robust Homo sapiens GSE94682 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: treated with 10nM R1881 for 4 hours Permissive Robust Homo sapiens GSE94682 ... MA0007.3
AR R1-AD1 (prostate cancer) Treatment: 0.1% DMSO + 1 nM ethanol for 4 hrs Permissive Robust Homo sapiens GSE96084 ... MA0007.3
AR R1-AD1 (prostate cancer) Treatment: 0.1% DMSO + 1 nM DHT for 4 hrs Permissive Robust Homo sapiens GSE96084 ... MA0007.3
AR R1-AD1 (prostate cancer) Treatment: 50 uM VPC14449 + 1 nM ethanol for 4 hrs Permissive Robust Homo sapiens GSE96084 ... MA0007.3
AR R1-D567 (prostate cancer) Treatment: 0.1% DMSO for 4 hrs Permissive Robust Homo sapiens GSE96084 ... MA0007.3
AR R1-D567 (prostate cancer) Treatment: 50 uM VPC14449 for 4 hrs Permissive Robust Homo sapiens GSE96084 ... MA0007.3
AR LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10nM DHT for 4 hrs Genotype: shGFP Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10 nM ETOH for 4 hrs Genotype: parental (none transfection) Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP95 Treatment: 10nM DHT for 4 hrs Genotype: shARv7 transfection Permissive Robust Homo sapiens GSE106559 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: transfected twice with with 5nM of siControl every 24 hours, 100nM of DHT for 2 hrs Permissive Robust Homo sapiens GSE108704 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: transfected twice with with 5nM of siControl every 24 hours, 100nM of ETOH for 2 hrs, 100nM of ETOH for 2 hrs Permissive Robust Homo sapiens GSE108704 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: transfected twice with with 5nM of siLINC00844 every 24 hours, 100nM of DHT for 2 hrs Genotype: transfected with siLINC00844 Permissive Robust Homo sapiens GSE108704 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: transfected twice with with 5nM of siLINC00844 every 24 hours, 100nM of ETOH for 2 hrs Genotype: transfected with siLINC00844 Permissive Robust Homo sapiens GSE108704 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: FA (control) Permissive Robust Homo sapiens GSE114737 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0007.3
AR primary prostate cancer Treatment: FA (control) Permissive Robust Homo sapiens GSE114737 ... MA0007.3
AR primary prostate cancer Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0007.3
AR primary prostate cancer Treatment: 2 mM DSG for 25 mins Permissive Robust Homo sapiens GSE114737 ... MA0007.3
AR caput epididymis Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: wildtype Tissue: Caput epididymis (containing initial segment) Permissive Robust Mus musculus GSE121151 ... MA0007.3
AR caput epididymis Age: 3 months Strain: C57Bl/6N; 129 hybrid Genotype: ArKI Tissue: Caput epididymis (containing initial segment) Permissive Robust Mus musculus GSE121151 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: vehicle, control; Permissive Robust Homo sapiens GSE43720 ... MA0007.3
AR LNCaP (prostate carcinoma) Treatment: 10 nm DHT; Permissive Robust Homo sapiens GSE43720 ... MA0007.3
AR LNCaP (prostate carcinoma) Genotype: Renilla knockout; Treatment: shRenilla; Permissive Robust Homo sapiens GSE120680 ... MA0007.3
AR LNCaP (prostate carcinoma) Genotype: GREB1 knockout; Treatment: shGREB1; Permissive Robust Homo sapiens GSE120680 ... MA0007.3
AR prostate cancer Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout; Permissive Robust Mus musculus GSE112414 ... MA0007.3
AR prostate cancer Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout; Permissive Robust Mus musculus GSE112414 ... MA0007.3
AR sperm Strain: CD1; Permissive Robust Mus musculus GSE116855 ... MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens ERP001226 MA0007.3
AR MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens ERP001226 MA0007.3
AR mdamb453 Permissive Robust Homo sapiens ERP001226 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE43785 MA0007.3
AR MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens GSE48930 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE63202 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE64656 MA0007.3
AR Permissive Robust Homo sapiens GSE72714 MA0007.3
AR 22RV1 (prostate carcinoma) Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR metastatic prostate cancer tissue Permissive Robust Homo sapiens GSE14092 ... MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE39879 ... MA0007.3
AR prostate Permissive Robust Mus musculus GSE47119 ... MA0007.3
AR prostate Permissive Robust Mus musculus GSE47119 ... MA0007.3
AR prostate Permissive Robust Mus musculus GSE47119 ... MA0007.3
AR prostate Permissive Robust Mus musculus GSE47119 ... MA0007.3
AR caput epididymis Permissive Robust Mus musculus GSE51106 ... MA0007.3
AR caput epididymis Permissive Robust Mus musculus GSE51106 ... MA0007.3
AR ventral prostate Permissive Robust Mus musculus GSE51106 ... MA0007.3
AR non-proliferating proximal caput epididymus Permissive Robust Mus musculus GSE38656 ... MA0007.3
AR ovarian granulosa cells Permissive Robust Homo sapiens GSE58628 ... MA0007.3
AR CWR22 (prostate carcinoma) Permissive Robust Homo sapiens GSE62442 ... MA0007.3
AR prostate tumor Permissive Robust Mus musculus GSE62645 ... MA0007.3
AR R1-D567 (prostate cancer) Permissive Robust Homo sapiens GSE102164 ... MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE79357 ... MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE80256 ... MA0007.3
AR fetal prostate fibroblasts Permissive Robust Homo sapiens GSE90772 ... MA0007.3
AR prostate cancer-associated fibroblasts Permissive Robust Homo sapiens GSE90772 ... MA0007.3
AR myofibroblasts Permissive Robust Homo sapiens GSE90772 ... MA0007.3
AR 22RV1 (prostate carcinoma) Permissive Robust Homo sapiens GSE96652 ... MA0007.3
AR VCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE98809 ... MA0007.3
AR HDF(human dermal fibroblasts) Permissive Robust Homo sapiens GSE107320 ... MA0007.3
AR LNCaP C4-2 (prostate carcinoma) Permissive Robust Homo sapiens GSE97831 ... MA0007.3
AR LNCaP (prostate carcinoma) foxa1 Permissive Robust Homo sapiens ERP003503 MA0007.3
AR mdamb453 foxa1 Permissive Robust Homo sapiens ERP003503 MA0007.3
AR VCaP (prostate carcinoma) dhat 18h Permissive Robust Homo sapiens GSE28950 MA0007.3
AR VCaP (prostate carcinoma) dhat 2h Permissive Robust Homo sapiens GSE28950 MA0007.3
AR lncap1f5 sifoxa1 Permissive Robust Homo sapiens GSE30623 MA0007.3
AR VCaP (prostate carcinoma) r1881 Permissive Robust Homo sapiens GSE32892 MA0007.3
AR VCaP (prostate carcinoma) r1881 10c26 Permissive Robust Homo sapiens GSE32892 MA0007.3
AR VCaP (prostate carcinoma) r1881 10c30 Permissive Robust Homo sapiens GSE32892 MA0007.3
AR VCaP (prostate carcinoma) r1881 1c26 Permissive Robust Homo sapiens GSE32892 MA0007.3
AR VCaP (prostate carcinoma) r1881 1c30 Permissive Robust Homo sapiens GSE32892 MA0007.3
AR LNCaP (prostate carcinoma) shctr r1881 hd Permissive Robust Homo sapiens GSE37345 MA0007.3
AR LNCaP (prostate carcinoma) shfoxa1 r1881 hd Permissive Robust Homo sapiens GSE37345 MA0007.3
AR 22RV1 (prostate carcinoma) dht Permissive Robust Homo sapiens GSE40050 MA0007.3
AR dht Permissive Robust Homo sapiens GSE40050 MA0007.3
AR LNCaP (prostate carcinoma) dht Permissive Robust Homo sapiens GSE40050 MA0007.3
AR LNCaP (prostate carcinoma) dht Permissive Robust Homo sapiens GSE43720 MA0007.3
AR DU145 (prostate carcinoma) arg56w Permissive Robust Homo sapiens GSE47987 MA0007.3
AR DU145 (prostate carcinoma) arq6540x Permissive Robust Homo sapiens GSE47987 MA0007.3
AR DU145 (prostate carcinoma) foxa1 arq6540x Permissive Robust Homo sapiens GSE47987 MA0007.3
AR DU145 (prostate carcinoma) foxa1 high Permissive Robust Homo sapiens GSE47987 MA0007.3
AR LNCaP (prostate carcinoma) dht100nm Permissive Robust Homo sapiens GSE48308 MA0007.3
AR LNCaP (prostate carcinoma) dht1nm Permissive Robust Homo sapiens GSE48308 MA0007.3
AR ar dht100nm Permissive Robust Homo sapiens GSE48308 MA0007.3
AR ar dht1nm Permissive Robust Homo sapiens GSE48308 MA0007.3
AR LNCaP (prostate carcinoma) shctr Permissive Robust Homo sapiens GSE52725 MA0007.3
AR LNCaP (prostate carcinoma) shgata2 Permissive Robust Homo sapiens GSE52725 MA0007.3
AR PC3(bone mets prostate adenocarcinoma) r1881 Permissive Robust Homo sapiens GSE54110 MA0007.3
AR VCaP (prostate carcinoma) dht mdv3100 Permissive Robust Homo sapiens GSE55062 MA0007.3
AR VCaP (prostate carcinoma) shpias1 r1881 Permissive Robust Homo sapiens GSE56086 MA0007.3
AR lhsar hoxb13 Permissive Robust Homo sapiens GSE56288 MA0007.3
AR lhsar lacz Permissive Robust Homo sapiens GSE56288 MA0007.3
AR prostate cancer Permissive Robust Homo sapiens GSE56288 MA0007.3
AR prostate normal Permissive Robust Homo sapiens GSE56288 MA0007.3
AR LNCaP (prostate carcinoma) dht24h Permissive Robust Homo sapiens GSE58428 MA0007.3
AR LNCaP (prostate carcinoma) dht24h shfoxa1 Permissive Robust Homo sapiens GSE58428 MA0007.3
AR VCaP (prostate carcinoma) dht24h Permissive Robust Homo sapiens GSE58428 MA0007.3
AR VCaP (prostate carcinoma) dht24h shfoxa1 Permissive Robust Homo sapiens GSE58428 MA0007.3
AR VCaP (prostate carcinoma) dht24h shfoxp1 Permissive Robust Homo sapiens GSE58428 MA0007.3
AR VCaP (prostate carcinoma) dht24h shrunx1 Permissive Robust Homo sapiens GSE58428 MA0007.3
AR VCaP (prostate carcinoma) etoh24h Permissive Robust Homo sapiens GSE58428 MA0007.3
AR 22RV1 (prostate carcinoma) arfl arvs Permissive Robust Homo sapiens GSE58478 MA0007.3
AR 22RV1 (prostate carcinoma) arvs Permissive Robust Homo sapiens GSE58478 MA0007.3
AR etoh shctr Permissive Robust Homo sapiens GSE61268 MA0007.3
AR r1881 shctr Permissive Robust Homo sapiens GSE61268 MA0007.3
AR LNCaP (prostate carcinoma) etoh shctr Permissive Robust Homo sapiens GSE61268 MA0007.3
AR LNCaP (prostate carcinoma) hotair Permissive Robust Homo sapiens GSE61268 MA0007.3
AR LNCaP (prostate carcinoma) r1881 hotair Permissive Robust Homo sapiens GSE61268 MA0007.3
AR LNCaP (prostate carcinoma) r1881 shctr Permissive Robust Homo sapiens GSE61268 MA0007.3
AR LNCaP (prostate carcinoma) r1881 Permissive Robust Homo sapiens GSE62492 MA0007.3
AR LNCaP (prostate carcinoma) shctr dht Permissive Robust Homo sapiens GSE62492 MA0007.3
AR LNCaP (prostate carcinoma) shfoxp1 dht Permissive Robust Homo sapiens GSE62492 MA0007.3
AR prostate res Permissive Robust Homo sapiens GSE65478 MA0007.3
AR LNCaP (prostate carcinoma) etoh Permissive Robust Homo sapiens GSE69043 MA0007.3
AR LNCaP (prostate carcinoma) r1881 Permissive Robust Homo sapiens GSE69043 MA0007.3
AR LNCaP (prostate carcinoma) rpmifbs Permissive Robust Homo sapiens GSE69043 MA0007.3
AR LNCaP (prostate carcinoma) shfoxa1 phfrpmifcs Permissive Robust Homo sapiens GSE69043 MA0007.3
AR LNCaP (prostate carcinoma) shfoxa1 rpmifbs Permissive Robust Homo sapiens GSE69043 MA0007.3
AR LNCaP (prostate carcinoma) shgata2 etoh Permissive Robust Homo sapiens GSE69043 MA0007.3
AR LNCaP (prostate carcinoma) shgata2 r1881 Permissive Robust Homo sapiens GSE69043 MA0007.3
AR mdamb453 r1881 Permissive Robust Homo sapiens GSE70161 MA0007.3
AR mdamb453 r1881 sictr Permissive Robust Homo sapiens GSE70161 MA0007.3
AR mdamb453 r1881 sipias1 Permissive Robust Homo sapiens GSE70161 MA0007.3
AR shpsa Permissive Robust Homo sapiens GSE71704 MA0007.3
AR dht Permissive Robust Homo sapiens GSE74069 MA0007.3
AR mpa Permissive Robust Homo sapiens GSE74069 MA0007.3
AR VCaP (prostate carcinoma) dht Permissive Robust Homo sapiens GSE79128 MA0007.3
AR VCaP (prostate carcinoma) r1881 Permissive Robust Homo sapiens GSE79128 MA0007.3
AR VCaP (prostate carcinoma) sh1 dht Permissive Robust Homo sapiens GSE79128 MA0007.3
AR VCaP (prostate carcinoma) sh1 r1881 Permissive Robust Homo sapiens GSE79128 MA0007.3
AR VCaP (prostate carcinoma) sh2 dht Permissive Robust Homo sapiens GSE79128 MA0007.3
AR VCaP (prostate carcinoma) sh2 r1881 Permissive Robust Homo sapiens GSE79128 MA0007.3
AR VCaP (prostate carcinoma) sh3 dht Permissive Robust Homo sapiens GSE79128 MA0007.3
AR LNCaP (prostate carcinoma) dht Permissive Robust Homo sapiens GSE83860 MA0007.3
AR LNCaP (prostate carcinoma) dht tnfa Permissive Robust Homo sapiens GSE83860 MA0007.3
AR LNCaP (prostate carcinoma) dmso Permissive Robust Homo sapiens GSE83860 MA0007.3
AR VCaP (prostate carcinoma) r1881 30m Permissive Robust Homo sapiens GSE84432 MA0007.3
AR VCaP (prostate carcinoma) r1881 4h Permissive Robust Homo sapiens GSE84432 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens ERP003503 MA0007.3
AR mdamb453 Permissive Robust Homo sapiens ERP003503 MA0007.3
AR VCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE28950 MA0007.3
AR lncap1f5 Permissive Robust Homo sapiens GSE30623 MA0007.3
AR VCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE32892 MA0007.3
AR 22RV1 (prostate carcinoma) Permissive Robust Homo sapiens GSE40050 MA0007.3
AR Permissive Robust Homo sapiens GSE40050 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE40050 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE43720 MA0007.3
AR DU145 (prostate carcinoma) Permissive Robust Homo sapiens GSE47987 MA0007.3
AR PC3(bone mets prostate adenocarcinoma) Permissive Robust Homo sapiens GSE54110 MA0007.3
AR VCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE55062 MA0007.3
AR VCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE56086 MA0007.3
AR 22RV1 (prostate carcinoma) Permissive Robust Homo sapiens GSE58478 MA0007.3
AR LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE62492 MA0007.3
AR prostate Permissive Robust Homo sapiens GSE65478 MA0007.3
AR Permissive Robust Homo sapiens GSE71704 MA0007.3
AR Permissive Robust Homo sapiens GSE74069 MA0007.3